Sublingual Dexmedetomidine

DRUG3 trials

Sponsors

Nourhan M.Aly, Massachusetts General Hospital, Lone Baandrup

Conditions

AgitationAnti-anxiety AgentsDeliriumModerate Sedation

Phase 2

Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment

CompletedNCT04237532

Nourhan M.AlyAnti-anxiety Agents, Moderate Sedation

Start: 2019-08-27End: 2020-08-10Updated: 2020-10-29

Acute Agitation in Emergency Psychiatry

RecruitingNCT06752616

Lone BaandrupAgitation

Start: 2024-12-30End: 2027-12-31Target: 132Updated: 2025-01-01

Phase 3

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

RecruitingNCT06192615

Massachusetts General HospitalDelirium

Start: 2025-01-06End: 2029-03-31Target: 1800Updated: 2025-12-31